secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-08-17T23:59:59+00:00
Accession:  0001493152-23-029250
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa presents at Sidoti conference; no material financial data disclosed
----------------------------------------------------------------------------

- Company presented on August 17, 2023, at the Sidoti Micro-Cap Virtual Conference.
- David Young, Pharm.D., Ph.D., presented the corporate update during Track 2 at 11:30 AM ET.
- Presentation is available on Processa's website under the Investors section.
- No specific clinical trial results, financial guidance, or pipeline changes were detailed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223029250/0001493152-23-029250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223029250/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-029250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer